Home> News> A call to leverage big data to accelerate blood cancer research

A call to leverage big data to accelerate blood cancer research

November 02, 2022 18:05 - x 00, 0 - 00:00


Big Data has proven to offer new insights that can contribute to advances in novel therapies and more efficient medicines. The HARMONY Alliance urges researchers across the globe to break data silos and embrace cooperation to foster blood cancer research. It takes one missing piece of data to eureka.

Data is knowledge. Access to data gives scientists and healthcare professionals insights into disease characteristics and correlations between different biomarkers. Today, artificial intelligence algorithms are already reimaging research in many disciplines of life sciences and medicine, and could help us harness the full power of data. Thankfully, one barrier stands in the way: data silos. However, this can be easily overcome if we start to cooperate closer and share data within a secure and trusted ecosystem.

Read our latest 'Manifesto' to learn more about our call to all stakeholders in healthcare and life sciences.

Click here to open the folder >

The HARMONY Alliance has been working  hard to collect data and speed up research on Hematologic Malignancies for the past six years. Over 100+ organizations from 18 European countries already share the HARMONY Alliance mission: personalized treatment for blood cancer patients.

Become involved! What can we offer you? Read more here >

Receive the latest news. Click here to subscribe!